Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Severe meningo-/encephalitis after daclizumab therapy for multiple sclerosis.
Stork L, Brück W, von Gottberg P, Pulkowski U, Kirsten F, Glatzel M, Rauer S, Scheibe F, Radbruch H, Hammer E, Stürner KH, Kaulen B, Heesen C, Hoffmann F, Brock S, Pawlitzki M, Bopp T, Metz I. Stork L, et al. Among authors: scheibe f. Mult Scler. 2019 Oct;25(12):1618-1632. doi: 10.1177/1352458518819098. Epub 2019 Jan 18. Mult Scler. 2019. PMID: 30657420
Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS.
Scheibe F, Metz I, Radbruch H, Siebert E, Wolf S, Köhnlein M, Harms L, Meisel A. Scheibe F, et al. Neurol Neuroimmunol Neuroinflamm. 2018 Jul 10;5(5):e479. doi: 10.1212/NXI.0000000000000479. eCollection 2018 Sep. Neurol Neuroimmunol Neuroinflamm. 2018. PMID: 30027105 Free PMC article. No abstract available.
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19.
Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, Laue M, Schneider J, Brünink S, Greuel S, Lehmann M, Hassan O, Aschman T, Schumann E, Chua RL, Conrad C, Eils R, Stenzel W, Windgassen M, Rößler L, Goebel HH, Gelderblom HR, Martin H, Nitsche A, Schulz-Schaeffer WJ, Hakroush S, Winkler MS, Tampe B, Scheibe F, Körtvélyessy P, Reinhold D, Siegmund B, Kühl AA, Elezkurtaj S, Horst D, Oesterhelweg L, Tsokos M, Ingold-Heppner B, Stadelmann C, Drosten C, Corman VM, Radbruch H, Heppner FL. Meinhardt J, et al. Among authors: scheibe f. Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. Epub 2020 Nov 30. Nat Neurosci. 2021. PMID: 33257876
Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy.
Huo S, Ferse C, Bösl F, Reincke SM, Enghard P, Hinrichs C, Treskatsch S, Angermair S, Eckardt KU, Audebert HJ, Ploner CJ, Endres M, Prüss H, Franke C, Scheibe F. Huo S, et al. Among authors: scheibe f. J Neurol. 2022 Aug;269(8):4013-4020. doi: 10.1007/s00415-022-11152-5. Epub 2022 May 10. J Neurol. 2022. PMID: 35538168 Free PMC article. No abstract available.
Clinical characteristics, treatments, outcome, and prognostic factors of severe autoimmune encephalitis in the intensive care unit: Standard treatment and the value of additional plasma cell-depleting escalation therapies for treatment-refractory patients.
Schwarz L, Akbari N, Prüss H, Meisel A, Scheibe F. Schwarz L, et al. Among authors: scheibe f. Eur J Neurol. 2023 Feb;30(2):474-489. doi: 10.1111/ene.15585. Epub 2022 Oct 17. Eur J Neurol. 2023. PMID: 36176208
102 results